Delivery Order SPE2DB20D2014-SPE2DB25FC69W
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,845.42 on August 5, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units). This is a firm fixed-price, non-set-aside contract with a completion date of August 6, 2025, and performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order was issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,194.12 on August 14, 2025, for OxyContin ER 30 mg tablets (100-count supply). This firm fixed price, non-set-aside contract is part of AmerisourceBergen's broader engagement with the DLA and represents a delivery order issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of OxyContin tablets 40mg, with a contract ceiling value of $2,508.63 and an ultimate completion date of July 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) valued at $1,458.52, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a single transaction under the contractor's larger pharmaceutical supply relationship with the federal government. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $3,009.06 to AmerisourceBergen Drug Corp for OxyContin ER 30 mg tablets (100-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This is a firm fixed-price, non-set-aside delivery order issued under a competitive procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,924.20 for OxyContin ER 10 mg tablets (100-count) with an ultimate completion date of July 30, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $4,012.32 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of OxyContin ER 40 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through an open procurement process. The pharmaceutical products will be delivered to the Conshohocken, Pennsylvania location by the ultimate completion date of August 12, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 10 mg tablets (100-count) valued at $1,908.93, with an ultimate completion date of August 1, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a $2,142.97 delivery order to AmerisourceBergen Drug Corp for OxyContin ER 30 mg tablets (100-count packages) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price contract, which received no set-aside designation, was competitively awarded and represents a child delivery order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical will be supplied from the vendor's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 30 mg tablets (100-count) valued at $1,640.40, with a firm fixed-price contract type and an ultimate completion date of July 30, 2025. This non-set-aside competitive award was issued on July 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within the company's broader federal...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC69WDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,992.89 to AmerisourceBergen Drug Corp for 100 tablets of OxyContin ER 40 mg, with an ultimate completion date of August 11, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement and represents a continuation of the vendor's pharmaceutical supply relationship with the federal government. The place of performance is identified as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a child contract under this prime IDV, the current delivery order exemplifies the company's role as a critical pharmaceutical distributor for military and federal healthcare systems. AmerisourceBergen's federal contract portfolio demonstrates extensive capability in supplying controlled substances, brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 8/8/25 |